Type(s) of biological therapy-Avastin Posts on Medivizor
Navigation Menu

Type(s) of biological therapy-Avastin Posts on Medivizor

Evaluating the effectiveness and safety of different bevacizumab schedules in combination with chemotherapy for the treatment of patients with metastatic colorectal cancer.

Evaluating the effectiveness and safety of different bevacizumab schedules in combination with chemotherapy for the treatment of patients with metastatic colorectal cancer.

Posted by on Aug 29, 2021 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of bevacizumab (Avastin) administered either on the same day or a few days before chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC). The data showed that bevacizumab administered 4 days before chemotherapy significantly improved overall survival with...

Read More

Does bevacizumab increase hemorrhage risk in metastatic colorectal cancer?

Posted by on Oct 24, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the risk of hemorrhage (blood loss) associated with bevacizumab (Avastin) treatment in metastatic (spread to other parts of the body) colorectal cancer patients. Researchers reported that bevacizumab significantly increases the risk of hemorrhage.  Some background The formation of new blood vessels is an...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor